Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Tables)

v3.24.1.1.u2
Net Income (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following common stock equivalents were not included in the calculation of net income (loss) per diluted share because their effect were anti-dilutive (in thousands):

 

 

Three months ended March 31,

 

 

2024

 

 

2023

 

Stock options

 

 

12,748

 

 

 

20,481

 

Performance stock options

 

 

6,750

 

 

 

11,000

 

Warrants

 

 

10,750

 

 

 

10,750

 

Total

 

 

30,248

 

 

 

42,231